SCHEMBL6202812

SCHEMBL6202812

CCc1nc(-c2ccc(OC(F)(F)F)cc2OC)c(OC)nc1C(N)c1ccc(OC)cc1

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 16/20 0.62
RUNX1 Q01196 1/20 0.35
CHRM5 P08912 1/20 0.35
CTSA P10619 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5406519 0.81 CRHR1 (0.68) CRHR1RUNX1
SCHEMBL6203918 0.80 CRHR1 (0.48) CRHR1RUNX1CTSA
SCHEMBL5414869 0.79 CRHR1 (0.68) CRHR1RUNX1CTSA
SCHEMBL5414310 0.78 CRHR1 (0.69) CRHR1CTSA
SCHEMBL5406545 0.77 CRHR1 (0.70) CRHR1
SCHEMBL5406509 0.77 CRHR1 (1.00) CRHR1
SCHEMBL5412848 0.76 CRHR1 (0.66) CRHR1
SCHEMBL5417192 0.75 CRHR1 (0.62) CRHR1RUNX1
SCHEMBL5420378 0.74 CRHR1 (0.63) CRHR1RUNX1
SCHEMBL4882817 0.73 CRHR1 (0.59) CRHR1RUNX1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554258-A1 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS NEUROGEN CORPORATION (US) 2005-07-20 EP disclosed
WO-2004018437-A1 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS NEUROGEN CORPORATION (US) 2004-03-04 WO disclosed